Invega Sustenna Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials
• Forums

A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal
Condition:   Schizophrenia Interventions:   Drug: Oral Antipsychotics (OAPs);   Drug: Paliperidone Palmitate 1-Month Formulation (PP1M) Sponsor:   Janssen-Cilag Farmaceutica Ltda. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2018 Category: Research Source Type: clinical trials